Search results
Gaming firm Nazara logs Rs 17 crore in net profit in Q4, revenue drops 8 pc
Investing.com· 12 hours agoGaming firm Nazara logs Rs 17 crore in net profit in Q4, revenue drops 8 pc
1 Impressive Stat That Highlights Just How Far Palantir's Business Has Come in a Decade
Motley Fool via Yahoo Finance· 41 minutes agoAnd there's one stat from the most recent letter to shareholders which caught my attention, and...
If EPS Growth Is Important To You, New York Times (NYSE:NYT) Presents An Opportunity
Simply Wall St. via Yahoo Finance· 4 hours agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
Here's Why We Think Miller Industries (NYSE:MLR) Might Deserve Your Attention Today
Simply Wall St. via Yahoo Finance· 4 hours agoInvestors are often guided by the idea of discovering 'the next big thing', even if that means...
Here's Why Kinaxis (TSE:KXS) Has Caught The Eye Of Investors
Simply Wall St. via Yahoo Finance· 4 hours agoFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a...
Héroux-Devtek Inc. Just Beat EPS By 36%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 3 hours agoAs you might know, Héroux-Devtek Inc. (TSE:HRX) just kicked off its latest yearly results with some...
Toronto-Dominion Bank Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 4 hours agoToronto-Dominion Bank (TSE:TD) Second Quarter 2024 Results Key Financial Results Revenue: CA$12.7b...
Should You Be Adding Graubündner Kantonalbank (VTX:GRKP) To Your Watchlist Today?
Simply Wall St. via Yahoo Finance· 9 hours agoInvestors are often guided by the idea of discovering 'the next big thing', even if that means...
Ralph Lauren Full Year 2024 Earnings: EPS Misses Expectations
Simply Wall St. via Yahoo Finance· 4 hours agoNet income: US$646.3m (up 24% from FY 2023). Profit margin: 9.7% (up from 8.1% in FY 2023). The...
2 Biotech Stocks to Buy in May
Motley Fool via Yahoo Finance· 3 hours agoVertex Pharmaceuticals has developed several medicines that address the underlying causes of CF, the only ones in the world. The biotech's monopoly in...
